期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

冠状动脉支架的研究与进展 被引量：1

下载PDF
导出
摘要 人类对冠心病的认识经历了漫长的过程，自从介入手术的广泛开展，特别是80年代经皮冠状动脉球囊扩张成形术和90年代冠脉内支架置入术的临床应用，开拓了冠心病特别是心肌梗死（心梗）治疗的全新局面。
作者 陈亚东
机构地区 总参警卫局卫生保健处
出处 《中国心血管杂志》 2009年第6期495-497,共3页 Chinese Journal of Cardiovascular Medicine
关键词 冠状动脉支架 经皮冠状动脉球囊扩张成形术 冠脉内支架置入术 介入手术 临床应用 心肌梗死 冠心病 认识经
分类号 R541.4 [医药卫生—心血管疾病]
  • 相关文献

参考文献24

  • 1Douglas JR. Role of adjunct pharmacologic therapy in the era of drug-eluting stents. Atheroscler, 2005, 6: 47-52.
  • 2Stone GW,Ellis SG, Cox DA, et al. One-year clinical results with the slow-release, polymer-based, paclitaxel-eluting TAXUS stent: The TAXUS-IV trial. Circulation, 2004, 109 : 1942- 1947.
  • 3Virmani R, Kolodgie FD, Farb A, et al. Drug eluting stents : Are human and animal studies comparable? Heart, 2003, 89: 133-138.
  • 4Joner M, Finn AV, Farb A, et al. Pathology of drug-eluting stents in humans: delayed healing and late thrombotic risk. J Am Coil Cardio1,2006,48 : 193-202.
  • 5Pfisterer M, Brunner-La Rocca HP, Buser PT, et al. Late clinical events after clopidogrel discontinuation may limit the benefit of drug-eluting stents: an observational study of drug eluting Versus bare-metal stents. J Am Coll Cardiol, 2006, 48 : 2584-2591.
  • 6Camenzind E, Steg PG, Wijns W. A meta-analysis of first generation drug-eluting stent programs. Presented at Hotline Session I, World Congress of Cardiology 2006, Barcelona, September 225, 2006, abstract.
  • 7Nordmann AJ, Briel M, Bucher HC. Mortality in randomized controlled trials comparing drug-eluting vs. bare metal stents in coronary artery disease : a meta-analysis. Eur Heart J, 2006,27 : 2784-2814.
  • 8Iakovou I,Schmidt T, Bonizzoni E, et al. Incidence, predictors, and outcome of thrombosis after successful implantation of dugeluting stents. JAMA ,2005 ,293 :2126-2130.
  • 9Stone GW,Moses JW, Ellis SG, et al. Safety and efficacy of sirolimus-and paclitaxel-eluting coronary stents. N Engl J Med, 2007,356:995-1008.
  • 10Stone GW,Ellis SG, Colombo A, et al. Offsetting impact of thrombosis and restenosis on the occurrence of death and myocardial infarction after paclitaxel-eluting and bare metal stent implantation. Circulation, 2007,115:2842-2847.

二级参考文献13

  • 1张玉霄,卢才义,薛桥,刘鹏,颜伟,吴兴利,陈瑞.载雷帕霉素可降解聚合物涂层支架治疗冠心病的临床观察[J].中华心血管病杂志,2006,34(11):971-974. 被引量：19
  • 2LIU Hai-bo XU Bo QIAO Shu-bin YANG Yue-jin MA Wei-hua QIN Xue-wen YAO Min WU Yong-jian YUAN Jin-qing CHEN Jue YOU Shi-jie DAI Jun XIA Ran LI Jian-jun CHEN Ji-lin GAO Run-lin.A comparison of clinical and angiographic outcomes after Excel bioabsorbable polymer versus Firebird durable polymer rapamycin-eluting stent for the treatment of coronary artery disease in a “real world” setting:six-month follow-up results[J].Chinese Medical Journal,2007(7):574-577. 被引量：15
  • 3Togni M, Windecker S, Cocchia R, et al. Sirolimus-eluting stents associated with paradoxic coronary vasoconstriction. J Am Coll Cardiol, 2005, 46:231-236.
  • 4Hong MK, Mintz GS, Lee CW, et al. Late stent malapposition after drug-eluting stent implantation: an intravaseular ultrasound analysis with long-term follow-up. Circulation, 2006,113:414-419.
  • 5Tina L, Pinto S, Ron W. Drug-eluting stent safety. Am J Cardiol, 2007,100 Suppl:10M-17M.
  • 6SERRUYS Patrick W, ONG Andrew TL, PIEK Jan J, et al. A randomized comparison of a durable polymer everolimus-eluting stent with a bare metal coronary stent: The SPIRIT first trial. EuroIntervention, 2005, 1: 58-65.
  • 7Stephen Windeeker. SPIRIT FIRST 4-Year Results Presentation, PCR 2008.
  • 8Khattab A, Riehardt G, Vefin V, et al. Differentiated analysis of an everolimus-eluting stent and a paelitaxel-eluting stent among higher risk subgroups for restnosis: results from the SPIRIT II trial. Eurolntervention, 2008,3: 566-573.
  • 9Gregg WS, Mark M, William N, et al. Comparison of an everolimus-eluting stent and a paclitaxel-eluting stent in patients with coronary artery disease : a randomized trial. JAMA ,2008,299 : 1903-1913.
  • 10Stone GW, Midei M, Newman W,et al. Randomized comparison of everolimus-eluting and paclitaxel-eluting stents: two-year clinical follow-up from the Clinical Evaluation of the Xience V Everolimus Eluting Coronary Stent System in the Treatment of Patients with de novo Native Coronary Artery Lesions (SPIRIT) III trial. Circulation,2009,119:680-686.

共引文献35

同被引文献6

引证文献1

二级引证文献2

中国心血管杂志
2009年 第6期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部